INHIB, A FACTOR WHICH INHIBITS CYTOKINE-ACTIVATED LEUKOCYTES

摘要

The present invention relates to a molecule (INHIB) which inhibits leukocyte immunological activity, processes for preparing and purifying the molecule, a screening assay, compositions containing INHIB, and diagnostic and therapeutic uses of the molecule. The structure of the INHIB molecule is shown to be substantially similar to the free β chain of complement C3.